New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease. - Abstract - Europe PMC
Expression of Membrane Bound O-Acyltransferase Domain Containing 7 after Myocardial Infarction and its Role in Lipid Metabolism in vitro
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis - Clinical Gastroenterology and Hepatology
IJERPH, Free Full-Text
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
PDF) MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease part 1: general aspects, epidemiology. pathophysiology and natural history
Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease
Frontiers MBOAT7-TMC4 rs641738 Is Not Associated With the Risk of Hepatocellular Carcinoma or Persistent Hepatitis B Infection
Nutrients, Free Full-Text
Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization study - Gellert‐Kristensen - 2023 - Liver International - Wiley Online Library
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. - Abstract - Europe PMC
